Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Glu5.5
Glucosamine – Forschung
Hilft vermutlich
237 begutachtete Studien
Was die Evidenz sagt
Hilft wahrscheinlich
Glucosamine scheint in 6 von 8 Studien mit messbaren Effekten zu helfen — die Evidenz tendiert klar ins Positive.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 1975–2026 mit einer typischen Studiengröße von 212 Teilnehmenden.
Basierend auf 237 Studien · 38 Meta-Analysen · 180 RCTs · 519,740 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
6geholfen2nicht geholfen· 229 weitere ohne bewertete Effektdaten
Nach Outcome
Joint pain & arthritisReduzierte Gelenkschmerzen und verbesserte Beweglichkeit innerhalb von 4-8 Wochen · 4-8 Wochen
Hilft wahrscheinlich156 Studien
Glucose & metabolic
Überwiegend Mechanismus / Beobachtung13 Studien
Safety profile
Überwiegend Mechanismus / Beobachtung5 Studien
InflammationKann Gelenkschmerzen lindern und den Knorpelabbau verlangsamen · 4-12 Wochen
Überwiegend Mechanismus / Beobachtung3 Studien
Therapeutic & clinical
Überwiegend Mechanismus / Beobachtung3 Studien
Heart & blood pressure
Zu wenige bewertete Studien1 Studie
In Zahlen
Aus 27 Studien mit messbaren Effekten gezogen
Wahrscheinlich echte Effekte
75%
über Studien hinweg
Untersuchte Personen
520k
typische Studie: 212 Personen
Stärkste Designs
218
38 gepoolt, 180 randomisiert
Zeigte Nutzen
75%
6/8 Studien
Wie lange Studien liefen
1–3 Monate
1
3+ Monate
7
Untersuchte Populationen
Patients with knee osteoarthritis6
Osteoarthritis patients4
Knee osteoarthritis patients2
General population2
Stetige Forschung
34 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2025
197520002026
1Safety of anti-osteoarthritis medicationsSystematische Übersichtn=22,938 · very large study2025
Einfach gesagt: This SR confirms previous evidence on the safety of anti-OA medications from meta-analyses of phase 3 RCTs.
Honvo G et al. · Drugs (2025)
This SR confirms previous evidence on the safety of anti-OA medications from meta-analyses of phase 3 RCTs.
Beyond the evidence here reported, the limitations of this research highlight the urgent need of a reporting guideline for post-marketing safety surveillance studies.
Importantly, real-life safety surveillance of anti-OA medications should be strengthened with large cohort studies with control groups, and results should be disaggregated by disease populations for drugs common to several conditions.
2Knee osteoarthritis treatment efficacyMeta-Analysen=1,067 · large study2023
Einfach gesagt: Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent.
Meng Z et al. · Archives of orthopaedic and trauma surgery (2023)
Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent.
It is worthwhile to popularize and apply the combination in KOA treatment considering the point of effect, tolerability and economic costs.
Additionally, regarding the limited number of studies and uneven trial quality, more high-quality trials are required to investigate the accurate clinical advantages of the combination.
3Knee osteoarthritis treatment effectivenessMeta-Analysen=1,930 · large study2022
Einfach gesagt: JWGT is considered effective and safe in the treatment of KOA and is worthy of clinical application.
Zhao J et al. · Journal of ethnopharmacology (2022)
Sehr groß Schaden
← SchlechterKein EffektBesser →
Likely real
The effective rate (OR = 2.56, 95% CI = 1.83 to 3.57, P < 0.001) and incidence of adverse reactions was significantly lower in the JWGT group than in the control group (OR = 0.13, 95% CI = 0.07 to 0.21, P < 0.001).
Compared with hyaluronic acid (HA) alone, JWGT + HA had better clinical efficacy (OR = 3.08, 95% CI = 1.48 to 6.40, P < 0.001).
JWGT is considered effective and safe in the treatment of KOA and is worthy of clinical application.
4Osteoarthritis pain improvementMeta-Analysen=2,952 · very large study2015
Einfach gesagt: Well-planned, well-conducted and well-published trials are warranted to improve the evidence for Ayurvedic interventions.
Kessler CS et al. · Rheumatology international (2015)
Sehr groß Nutzen
← SchlechterKein EffektBesser →
Likely real
For the compound preparation, Rumalaya, large and apparently unbiased effects beyond placebo were found for pain (standardized mean difference [SMD] -3.73; 95 % confidence interval [CI] -4.97, -2.50; P < 0.01) and global improvement (risk ratio 12.20; 95 % CI 5.83, 25.54; P < 0.01).
There is also some evidence that effects of the herbal compound preparation Shunti-Guduchi are comparable to those of glucosamine for pain (SMD 0.08; 95 % CI -0.20, 0.36; P = 0.56) and function (SMD 0.15; 95 % CI -0.12, 0.36; P = 0.41).
No severe adverse events were observed in all trials.
5Knee osteoarthritis symptomatic efficacyMeta-Analysen=16,427 · very large study2015
Einfach gesagt: The present study provided evidence for the symptomatic efficacy of glucosamine plus chondroitin in the treatment of knee OA.
Zeng C et al. · Scientific reports (2015)
All treatment options showed clinically significant improvement from baseline pain, but only glucosamine plus chondroitin showed clinically significant improvement from baseline function.
In terms of the structure-modifying effect, both glucosamine alone and chondroitin alone achieved a statistically significant reduction in joint space narrowing.
The present study provided evidence for the symptomatic efficacy of glucosamine plus chondroitin in the treatment of knee OA.
Einfach gesagt: A review of randomized trials of mostly low quality reveals that chondroitin (alone or in combination with glucosamine) was better than placebo in improving pain in participants with osteoarthritis in short-term studies.
Singh JA et al. · The Cochrane database of systematic reviews (2015)
Loss of minimum joint space width in the chondroitin group was statistically significantly less than in the placebo group, with a relative risk difference of 4.7% less (95% CI 1.6% to 7.8% less; n = 2 trials) (level of evidence, high; risk of bias, low).
Chondroitin was associated with statistically significantly lower odds of serious adverse events compared with placebo with Peto odds ratio of 0.40 (95% CI 0.19 to 0.82; n = 6 trials) (level of evidence, moderate).
Chondroitin did not result in statistically significant numbers of adverse events or withdrawals due to adverse events compared with placebo or another drug.
7Osteoarthritis and joint pain managementSystematische Übersichtn=146 · medium study2025
Einfach gesagt: Overall, the evidence suggests that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain.
Baden KER et al. · Nutrients (2025)
Of the 2013 articles screened, 146 studies were included in our review, with nearly 60% being randomized controlled trials and most conducted in Europe, Asia, or the U.S.
Most studies focused on osteoarthritis and joint pain, with over 90% of efficacy studies reporting positive outcomes and most safety studies indicating minimal or no adverse effects.
Overall, the evidence suggests that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain.